Company news

TransCode Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio

July 10, 2022

TransCode Therapeutics Receives National Institutes of Health (NIH) Notice of Award

May 31, 2022

TransCode Therapeutics Acquires Option for Radiotheranostic Technology

May 18, 2022

TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update

May 15, 2022

TransCode Therapeutics Reports 2021 Results; Provides Business Update

March 30, 2022

TransCode Therapeutics Reports Business Progress and Third Quarter 2021 Financial Results

November 14, 2021

TransCode Therapeutics Announces Participation in the Q4 Virtual Investor Summit

November 8, 2021

TransCode Therapeutics Appoints Zdravka Medarova, Ph.D., as Chief Technology Officer

September 29, 2021

TransCode Therapeutics Announces Publication in Cancer Nanotechnology of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Metastatic Breast Cancer

September 22, 2021

TransCode Therapeutics Reports Business Progress and Second Quarter 2021 Financial Results

August 22, 2021

TransCode Therapeutics Awarded Funding from National Institutes of Health (NIH) to Support Clinical Evaluation of TTX-MC138

August 4, 2021

TransCode Therapeutics, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters' Over-allotment Option

July 12, 2021

TransCode Therapeutics, Inc. Announces Pricing of Initial Public Offering

July 7, 2021

← Newer news releases

Decks

The 5 newest of 6 decks. Every deck is listed under its year.